Michelson Medical Research Foundation
Michelson Medical Research Foundation reported 21 stocks worth $108M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are IVE (10.9%), VEA (10.4%) and BLDR (8.0%). Compared with Q1 2026, the fund opened new positions in BLDR and CME and sold out of MTN and UNH.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  IVE Ishares TR | $11.8M | 10.9% | 52K | No change | 8 of 8 | |
| 2 |  VEA Vanguard Tax-Managed Fds | $11.3M | 10.4% | 158K | No change | 8 of 8 | |
| 3 |  BLDR Builders Firstsource Inc | $8.7M | 8.0% | 97K | New position | 1 of 8 | |
| 4 |  CME Cme Group Inc | $8.6M | 8.0% | 39K | New position | 1 of 8 | |
| 5 |  VWO Vanguard Intl Equity Index F | $7.6M | 7.0% | 128K | No change | 8 of 8 | |
| 6 |  IWC Ishares TR | $7.1M | 6.5% | 35K | No change | 8 of 8 | |
| 7 |  CNNE Cannae Hldgs Inc | $6.9M | 6.4% | 481K | No change | 2 of 8 | |
| 8 |  IBB Ishares TR | $6.7M | 6.2% | 35K | No change | 8 of 8 | |
| 9 |  KRE Spdr Series Trust | $4.8M | 4.4% | 64K | No change | 8 of 8 | |
| 10 |  SAFE Safehold Inc | $4.7M | 4.3% | 297K | No change | 5 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Michelson Medical Research Foundation 13F FAQ
What does Michelson Medical Research Foundation own?
Michelson Medical Research Foundation reported 21 stocks worth $108M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are IVE (10.9%), VEA (10.4%) and BLDR (8.0%). The table above lists every position in the filing (the top 10 without an account).
What did Michelson Medical Research Foundation buy and sell in Q2 2026?
Compared with Q1 2026: 2 new positions, 0 added to, 0 trimmed and 2 sold out. New positions include BLDR and CME. It sold all of MTN and UNH.
When will Michelson Medical Research Foundation file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Michelson Medical Research Foundation's portfolio worth?
The Q2 2026 filing reports $108M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.